Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Sang-Wook Shin, Woo Kyoung Jeong, Sanghyeok Lim, Yongsoo Kim, Jinoo Kim

Clin Mol Hepatol. 2015;21(1):71-79. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.71

View: 7287 Download: 103 Web of Science: 2 Crossref: 3

Seung Hyun Kim, Woo Kyoung Jeong, Yongsoo Kim, Min Yeong Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2013;19(1):92-96. Published online March 25, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.1.92

View: 7100 Download: 76 Web of Science: 10 Crossref: 11

Woo Jung Choi, Woo Kyoung Jeong, Yongsoo Kim, Jinoo Kim, Ju Yeon Pyo, Young Ha Oh

Clin Mol Hepatol. 2012;18(1):101-104. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.101

View: 8035 Download: 59 Crossref: 6

1 |

Viewed By 5374	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5335	MAFLD: How is it different from NAFLD?
Viewed By 5220	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3901	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3867	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search